The Smart Phone Psychiatrist (The Atlantic, Jun 19, 2017) | The Soprano And The Scientist (NPR, Jun 05, 2017) | The Curious Case Of Phineas Gage (NPR, May 28, 2017) | Human Brain as Time Machine (NYMag, Apr 30, 2017) | Neuroscience of singling (UpLift, Apr 18, 2017) | The Neuroscience of Seeing an Ex (Discover Magazine, Mar 19, 2017) | How to keep your brain young (INC, Mar 05, 2017) | The neuroscience of humor (Medical News Today, Mar 05, 2017) | Your brain on politics (UVA Today, Mar 05, 2017) | Take two pills... (Psychiatric Times, Jan 20, 2017) | Promise and Perils of Pot (ScienceNews, Jan 16, 2017) | Witnessing fear can change your brain (ScienceDaily, Jan 12, 2017)

ACNP Spotlight

Logo

The 56th Annual Meeting closed with over 1800 members and scientific guests in attendance.  All attendees are urged complete the 2017 Annual Meeting Evaluation.  Attendees wishing to request CME credits must first complete the annual meeting evaluation. 

Congratulations to our 2018 New MembersAssociate Members, and Promotions   

56th Annual Meeting:
Evaluation and CME Request
Abstracts
E-Poster Gallery
Itinerary Planner
Travel Awardees

_____________________________________ 

NPP Podcast - Opioid Release after High-Intensity Interval Training in Healthy Human Subjects

Neuropsychopharmacology ReviewsThe Immunology of Behavior — Exploring the Role of the Immune System in Brain Health and Illness   

The Critical Role of Nonhuman Primates in Medical Research

Animal Research Committe Blog

Minority Task Force Report on Initiatives  

Brief: Finding the Right Treatment for Depression

NIMH Directors Blog
NIDA Directors Blog

Are you receiving Neuropsychopharmacology e-alerts?
Sign up with your e-mail address to receive monthly table of contents alerts and keep informed with Neuropsychopharmacology news and announcements.  Each e-alert features the latest journal commentaries, circumspectives, original research and review articles. 

Neuro News Corner

Article- The opioid epidemic spurs a search for new, safer painkillers

Last year, Joan Peay slipped on her garage steps and smashed her knee on the welcome mat. Peay, 77, is no stranger to pain. The Tennessee retiree has had 17 surgeries in the last 35 years — knee replacements, hip replacements, back surgery. She even survived a 2012 fungal meningitis outbreak that sickened her and hundreds of others, and killed 64. This knee injury, though, “hurt like the dickens.”

When she asked her longtime doctor for something stronger than ibuprofen to manage the pain, he treated her like a criminal, Peay says. His response was frustrating: “He’s known me for nine years, and I’ve never asked him for pain medicine other than what’s needed after surgery,” she says. She received nothing stronger than over-the-counter remedies. A year after the fall, she still lives in constant pain.

Just five years ago, Peay might have been handed a bottle of opioid painkillers for her knee. After all, opioids — including codeine, morphine and oxycodone — are some of the most powerful tools available to stop pain.

But an opioid addiction epidemic spreading across the United States has soured some doctors on the drugs. Many are justifiably concerned that patients will get hooked or share their pain pills with friends and family. And even short-term users risk dangerous side effects: The drugs slow breathing and can cause constipation, nausea and vomiting.

A newfound restraint in prescribing opioids is in many cases warranted, but it’s putting people like Peay in a tough spot: Opioids have become harder to get. Even though the drugs are far from perfect, patients have few other options. - Read More (Source - Science News, Images - FEDERICO GASTALDI)

Deadlines

 

*All submission deadlines are 5:00 PM Central time.

10/27/2017-Registration fees increase by $50.

11/30/2017-Registration fees will be refunded, less a $30 processing fee, if the Executive Office receives written notice to acnp@acnp.org.  

 

Welcome to the ACNP website

Welcome to the website of the American College of Neuropsychopharmacology (ACNP), a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.

Neuropsychopharmacology

About the CoverWith a 2016 impact factor of 6.403 NPP ranks 12th of 142 Psychiatry journals, 14th of 256 Pharmacology and Pharmacy journals, and 21st of 258 Neuroscience journals. 68% of accepted articles are published online in less than 25 business days and in print in less than 111 business days. In 2016, all issues of Neuropsychopharmacology were published on or ahead of schedule. SUBMIT YOUR ARTICLE HERE.

NPP Reviews

NPP ReviewPublished each January as a special collection of review articles, the 2016 issue of NPPR addresses Neurodevelopment and the Origins of Brain Disorders.  Neuropsychopharmacology Reviews

Statement of Inclusion

The ACNP actively promotes and recognizes principles of fairness, equity, and social justice in relation to, and across, intersections of race, age, color, disability, faith, religion, ancestry, national origin, citizenship, sex, sexual orientation, social class, economic class, ethnicity, gender identity, gender expression, and all other identities represented among our diverse membership.